HOME > ÇÁ·Î±×·¥ > Symposium
ÁÖ¿ä ÇÁ·Î±×·¥
5¿ù 2ÀÏ(SAT)
Plenary Lecture I
10:20~11:10
Thyroid Hormone Receptors, Mutations, and Cancer Development
Sheue-yann Cheng (NIH, USA)
5¿ù 3ÀÏ(SUN)
Plenary Lecture II
10:10~11:00
Regulation of skeletal homeostasis by PTH receptor signaling in osteocytes.
Teresita Bellido (Indiana Univ., USA)
¸ÞÀÎ ½ÉÆ÷Áö¾ö
5¿ù 2ÀÏ(SAT)
Bone
11:10~12:40
Transcriptional regulation of osteoblast and chondrocyte differentiation from mesenchymal cells
Riko Nishimura (Osaka Univ., Japan)
Wnt/beta-catenin signaling and bone formation
ÃÖ°·Ä(¿¬¼¼´ë)
Wnt regulators in angiogensis
±Ç¿µ±Ù(¿¬¼¼´ë)
Diabetes & Obesity
11:10~12:40
Vesicular glutamate transporter acts as a metabolic regulator
Moriyama Yoshinori (Okayama Univ, JPN)
Macroautophagy in homeostasis of pancreatic beta-cell
À̸í½Ä(¼º±Õ°üÀÇ´ë)
Cellular mechanism of high glucose/palmitate-induced beta cell death
°¿±(¾ÆÁÖ´ë)
Thyroid Gland
11:10~12:40
Hypothalamic regulation of thyroid function and metabolism
Masanobu Yamada (Gunma Univ. JPN)
Alterations of cellular metabolism by oncogenic BRAF activation in thyroid cancer
¼Û¹ÎÈ£(Ãæ³²ÀÇ´ë)
Thyroid hormonal effects on hepatic metabolism
¹Ú¿µÁÖ(¼¿ïÀÇ´ë)
Vascular Endocrinology
13:50~15:20
Pathophysiologic role of CRP in atheroslcerosis
Á¤ÂùÈñ(¼øõÇâÀÇ´ë)
CRP and insulin resistance
ÀÓ¼ö(¼¿ïÀÇ´ë)
CRP as a treatment guide for preventing MI
ÀÌ¿ø¿µ(¼º±Õ°üÀÇ´ë)
Neuroendocrinology (Basic)
13:50~15:20
Hypothalamic regulation of glucose homeostasis
Michael Cowley (Monash Univ, AUS)
Hypothalamic Nuclear Factor-kappa B regulates food intake and body weight
±è¹Î¼±(¿ï»êÀÇ´ë)
Enhanced Hypothalamic Leptin Signaling in Mice Lacking Dopamine D2 receptors
¹éÀÚÇö(°í·Á´ë)
Reproductive Endocrinology
13:50~15:20
Hyperandrogenism in diagnosis of PCOS
ÀÌÁö¿µ(°Ç±¹ÀÇ´ë)
Criteria for ovarian untrasound in dianosing PCOS
¹Ú¿øÀÏ(À»ÁöÀÇ´ë)
Metabolic test in women with PCOS
¿ÀÁö¿µ(ÀÌÈÀÇ´ë)
5¿ù 3ÀÏ(SUN)
Bone
11:00~12:30
From Bench to Clinic
Çѱâ¿Á(°üµ¿ÀÇ´ë)
Potential Risk of Bisphosphonates
º¯µ¿¿ø(¼øõÇâÀÇ´ë)
ONJ - Rare complication? How to prevent and manage?
ÃÖÇѼ®(¿¬¼¼ÀÇ´ë)
Diabetes & Obesity
11:00~12:30
Molecular mechanisms underlying fat-induced insulin resistance in the liver
ÃÖö¼ö(°¡ÃµÀÇ´ë)
Metabolic derangements found in fatty liver, NASH, and liver cirrhosis
±èöÈñ(¼øõÇâÀÇ´ë)
Orphan nuclear receptor SHP and non-alcoholic steatohepatitis
ÃÖÈï½Ä(Àü³²´ë)
Thyroid Gland
11:00~12:30
Functional aspect of Pendrin
Peter Kopp (NW Univ., USA)
Electrophysiology of pendrin, sodium iodide symporter and other ion channels in the thyroid
Akio Yoshida (Tottori Univ, JPN)
Pendrin mutation and hearing loss
¹ÚÈ«ÁØ(¼Ò¸®À̺ñÀÎÈÄ°ú)
Adrenal Gland
14:30~16:00
Endocrine hormone and hypertension
Hirotaka Shibata (Keio Univ., JPN)
Clinical implication of adrenal vein sampling in patients with primary Aldosteronism
±è¼º¿¬(¼¿ïÀÇ´ë)
Nuclear Medicine Imaging of Adrenal Gland Tumor
±èżº(±¹¸³¾Ï¼¾ÅÍ)
Aging
14:30~16:00
Problems of Sarcopenia in Aging
¹Ú¼®¿ø(Â÷ ÀÇ°úÇдëÇÐ)
Sarcopenia and insulin resistance in the Korean Longitudinal Study on Health and Aging (KLoSHA)
ÀåÇÐö(¼¿ïÀÇ´ë)
Effects of increased and decreased physical activity on sarcopenia and functional capacity in elderly people
William J. Evans (Arkansas Univ, USA)
Lipid
14:30~16:00
The function, composition, and particle size of lipoprotein
Á¶°æÇö(¿µ³²´ë)
Optimal approach to atherogenic dyslipidemia
ÀÌ»óÇÐ(¿¬¼¼ÀÇ´ë)
Emerging atherosclerotic risk factors in diabetic patients
ÇѱâÈÆ(¿ï»êÀÇ´ë)
Neuroendocrinology (Clinical)
14:30~16:00
Medical approach to hyperprolactinemia and prolactinoma
À¯¼øÁý(°¡Å縯ÀÇ´ë)
Prolactinoma in pregnancy
Áöº´Ã¶(¼¿ïÀÇ´ë)
Approach to invasive prolactinoma
±è¼±È£(¿¬¼¼ÀÇ´ë)